
-
Apple to invest additional $100 bn in US
-
Trump says likely to meet Putin 'very soon'
-
Major climate-GDP study under review after facing challenge
-
Lebanon's Hezbollah rejects cabinet decision to disarm it
-
Rare 'Hobbit' first edition auctioned for £43,000
-
Sinner lukewarm on expanded Cincinnati format
-
Rested Scheffler ready to tackle US PGA Tour playoffs
-
Sudan says army destroys Emirati aircraft, killing 40 mercenaries
-
White House says Trump open to meeting Putin and Zelensky
-
Grok, is that Gaza? AI image checks mislocate news photographs
-
'Global icon' Son Heung-min joins LAFC from Tottenham
-
In Cuba, Castro's 'influencer' grandson causes a stir
-
Mexican president backs threatened female football referee
-
German great Mueller signs with MLS Whitecaps
-
US government gets a year of ChatGPT Enterprise for $1
-
Egypt sets opening of $1 bn Pyramids museum for Nov 1
-
Prince Harry, African charity row rumbles on as watchdog blames 'all parties'
-
Brazil seeks WTO relief against Trump tariffs
-
Isak told to train alone by Newcastle - reports
-
McDonald's sees US rebound but says low-income diners remain stressed
-
Trump hikes India levy over Russian oil as tariff deadline approaches
-
Swiss president hopes Washington talks avert surprise tariff
-
France wildfire kills one as Spanish resort evacuated
-
Stocks higher with eyes on earnings, US tariff deadline
-
Vonn appoints Svindal as coach ahead of 2026 Olympics
-
Backlash after 'interview' with AI avatar of US school shooting victim
-
Darth Vader's lightsaber could cost you an arm and a leg
-
Swiss president to meet Rubio as surprise tariff hike looms
-
Israel orders army to execute govt decisions on Gaza
-
Italy approves plans for world's longest suspension bridge
-
Arsenal have 'belief' to end trophy drought, says Arteta
-
Putin decree allows Russia to increase greenhouse gas emissions
-
Putin holds 'constructive' talks with US envoy Witkoff ahead of sanctions deadline: Kremlin
-
Liverpool set to cut losses with Nunez move to Saudi: reports
-
Stocks tick up with eyes on earnings, US tariff deadline
-
German broadcast giant backs takeover by Berlusconi group
-
Pro-Trump nationalist becomes Poland's new president
-
Putin meets US envoy Witkoff ahead of sanctions deadline
-
UK watchdog bans Zara ads over 'unhealthily thin' model photos
-
Natural disasters caused $135 bn in economic losses in first half of 2025: Swiss Re
-
Rebuilding in devastated Mariupol under Russia's thumb
-
One dead, nine injured in huge France wildfire
-
German factory orders fall amid tariff, growth woes
-
Turkmenistan's methane-spewing 'Gateway to Hell' loses its anger
-
Markets tick up but traders wary as Trump tariffs temper rate hopes
-
A year on, Ugandans still suffering from deadly garbage collapse
-
Ozempic maker Novo Nordisk posts strong results but competition weighs
-
Prince Harry cleared of 'bullying' in African charity row
-
Taiwan's orchid growers dig in as US tariffs shoot up
-
Cuba activists say detained on anniversary of 1994 anti-Castro protest
CMSC | -0.52% | 22.95 | $ | |
SCU | 0% | 12.72 | $ | |
RBGPF | 1.42% | 76 | $ | |
CMSD | 0.13% | 23.54 | $ | |
BCC | -4.64% | 82.92 | $ | |
NGG | 0.03% | 72.3 | $ | |
SCS | 0.19% | 15.99 | $ | |
GSK | -1.55% | 36.75 | $ | |
RIO | 0.65% | 60.09 | $ | |
RELX | -3.65% | 48.81 | $ | |
BTI | 0.99% | 56.4 | $ | |
RYCEF | 0.9% | 14.48 | $ | |
JRI | 0.6% | 13.34 | $ | |
AZN | -1.2% | 73.6 | $ | |
VOD | 1.77% | 11.3 | $ | |
BCE | -1.33% | 23.25 | $ | |
BP | 0.83% | 33.88 | $ |

Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
P.Vogel--VB